Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Colorcon
Daiichi Sankyo
Boehringer Ingelheim
Citi
Healthtrust
Harvard Business School
Queensland Health
Argus Health

Generated: January 19, 2018

DrugPatentWatch Database Preview

Moexipril hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for moexipril hydrochloride and what is the scope of moexipril hydrochloride freedom to operate?

Moexipril hydrochloride
is the generic ingredient in two branded drugs marketed by Apotex Inc, Chartwell Rx, Glenmark Generics, Teva, and Ucb Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for moexipril hydrochloride. Seven suppliers are listed for this compound.
Pharmacology for moexipril hydrochloride

US Patents and Regulatory Information for moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 077536-002 Nov 30, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 078454-002 Jun 2, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 090416-002 Mar 30, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 090416-001 Mar 30, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 076204-002 May 8, 2003 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-002 Apr 19, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 078454-001 Jun 2, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-001 Apr 19, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chartwell Rx MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 077536-001 Nov 30, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 076204-001 May 8, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-001 Apr 19, 1995 ➤ Subscribe ➤ Subscribe
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-001 Apr 19, 1995 ➤ Subscribe ➤ Subscribe
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-002 Apr 19, 1995 ➤ Subscribe ➤ Subscribe
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-002 Apr 19, 1995 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Citi
McKesson
Dow
Accenture
QuintilesIMS
US Department of Justice
Argus Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot